Global Biochips Market By Product Overview
Biochips Market was valued at US$ 10.5 billion in 2024 and is projected to grow at a CAGR of 14.8% to reach US$ 41.8 billion by 2034.
The complete fundamental functional unit that has capability to perform many biochemical tasks simultaneously is known as a biochip. The biochip is a miniature laboratory with a microarray that is arranged on a solid substrate having capability of performing multi biochemical tasks and thus allowing higher throughput of speed and volume. The adaptable applications of biochips are considered as a vital advancement in medical technology. Biochips are largely used for research in drug discovery and development, proteomics, genomics and molecular diagnostics.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Biochips Market By Product Dynamics
Increasing application of biochips in the medical sector for cancer treatment, as biochips can detect cancer even before the development of symptoms, and diagnose it, which is the major factors driving the global biochips market growth. For instance, according to World Health Organization, in September 2018, with an estimated 9.6 million deaths in 2018, cancer has become the second leading cause for death worldwide.
Additionally, it can easily detect virulent diseases such as small pox, anthrax and plague due to which it has a wide application in the healthcare sector and hence flourishing the target market. For instance, according to World Health Organization, in October 2017, plague is termed as severe disease with a fatality ratio of 30%-60% for bubonic type and 100% for pneumonic type when left untreated.
Furthermore, factors such as computerization of biochemical processes through the use of biochips, readiness of molecular information, and application of biochips for gene and protein identification are set to drive the global biochips market. Moreover, advancement in the technology in the biochips like microfluidics, DNA microarray, etc. is expected to drive the growth of the biochips market globally.
However, lack of proper knowledge about biochip technology is a major restraint to the global biochips market which is dropping the demand for biochip products. Further, variable cost of the adaption of the biochips also affects the target market adversely. Favorable economic reforms and surging mergers and acquisitions among major biochips companies are the leading driving forces for the global biochips market in the forecast period.
Global Biochips Market By Product Segmentation
The biochips market report segments the market on the basis of product, application, end-user, and region.
On the basis of Product Type, the biochips market is segmented into DNA Chip, Protein Chip, Lab-on-a-chip, and Others. On the basis of Application, the target market is segmented into Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others. Based on End User the market is segmented into Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
For detailed understanding of market dynamics, the biochips market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. North America market leads the biochips market in terms of revenue contribution as compared to that of markets in other regions. This is due to presence of government initiatives, well-developed healthcare infrastructure and significant number of ongoing research activities in the region. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue owing to the developing healthcare infrastructure, increasing adoption for biochips over conventional bulky instruments.
Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 10.5 billion |
|
Projected Market Size 2034 |
US$ 41.8 billion |
|
CAGR Growth Rate |
14.8% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product - DNA Chip, Protein Chip, Lab-on-a-chip, and Others By Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others By End-User - Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Biochips Market report based on Product, Application, End-user and region:
Biochips Market, By Product:
- DNA Chip
- Protein Chip
- Lab-on-a-chip
- Others
Biochips Market, By Application:
- Drug Discovery & Development
- Disease Diagnostics
- Genomics
- Proteomics
- Agriculture
- Others
Biochips Market, By End-user:
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
- Others
Biochips Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Biochips Market By Product Key Players
Some of the prominent players operating in the biochips market include CDI laboratories, ThermoFisher Scientific, Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., InDevR Inc., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc., Randox Laboratories Ltd
Technological advancements in the product as well as strategic partnerships are some trends witnessed in the global biochips market. For instance, in July 2018, Agilent Technologies Inc. announced that it has completed the procurement of the business assets of ULTRA Scientific, Inc. which is a leading provider of chemical standards and certified reference materials. Further, in May 2017, CDI Labs expands HuProt which is the highest content human proteome microarray in the world in which over 1000 new recombinant proteins will be added.
Global Biochips Market By Product Key Issues Addressed
- In June 2023, ACROBiosystems, through ACRO Certify and under its Aneuro brand, announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, the two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization.
- In November 2023, ASU students break new ground with axoniverse’s innovative biochip technology aims to improve computing efficiency with neurons, could be released as early as next year. This student company is redefining the boundaries between biology and technology by developing a first-of-its-kind biochip, Axomini, slated for release in 2024.
Global Biochips Market By Product Company Profile
- ThermoFisher Scientific*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- CDI laboratories
- Affymetrix Inc.
- Illumina Inc.
- GE Healthcare Ltd.
- InDevR Inc.
- Agilent Technologies Inc.
- Fluidigm Corporation
- Cepheid Inc.
- Randox Laboratories Ltd
“*” marked represents similar segmentation in other categories in the respective section.
Global Biochips Market By Product Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Healthcare Data Storage Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Deployment
- Market Snippet, By Architecture
- Market Snippet, By End-User
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- DNA Chips
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Protein Chips
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Lab-On-A-Chip
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
- Overview Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Drug Discovery & Development
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Disease Diagnostics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Genomics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Proteomics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Agriculture
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others
- Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Biotechnology & Pharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Hospitals & Diagnostics Centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Academic & Research Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- CDI laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- ThermoFisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Affymetrix Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Illumina Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- GE Healthcare Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- InDevR Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Agilent Technologies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Fluidigm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Cepheid Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
The Last Word
- Future Impact
- About Us
- Contact
FAQs
Biochips market is segmented based on Product Type, Application, End User & Region.
Increasing application of biochips in the medical sector for cancer treatment, as biochips can detect cancer even before the development of symptoms, and diagnose it, which is the major factors driving the global biochips market growth.
North America market leads the global biochips market in terms of revenue contribution as compared to that of markets in other regions.
Some of the prominent players operating in the global biochips market include CDI laboratories, ThermoFisher Scientific, Affymetrix Inc., Illumina Inc., GE Healthcare Ltd., InDevR Inc., Agilent Technologies Inc., Fluidigm Corporation and Cepheid Inc.